Novo Holdings A/S

http://dbpedia.org/resource/Novo_Holdings_A/S an entity of type: Thing

Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK. rdf:langString
Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. rdf:langString
rdf:langString Novo Holdings
rdf:langString Novo Holdings A/S
rdf:langString Novo Holdings A/S
rdf:langString Novo Holdings A/S
xsd:integer 43319645
xsd:integer 1123132760
rdf:langString (Approx. $93.73 billion )
<danishKrone> 6.97E11
xsd:integer 1999
rdf:langString Asset management
rdf:langString Life Sciences
rdf:langString Lars Rebien Sørensen
rdf:langString Kasim Kutay
rdf:langString Novo Holdings logo.svg
rdf:langString Investments in Life Science
rdf:langString
rdf:langString Private limited company
rdf:langString Novo Holdings A/S ist ein dänischer Pharmahersteller; zu der Novo-Gruppe gehören die eigenständigen agierenden Tochterunternehmen Novo Nordisk, Novozymes und .Die Novo Holdings gehört der Novo Nordisk Foundation und ist Hauptanteilseigner der drei Pharmaunternehmen. Sitz der Novo Holdings ist Hellerup in Dänemark. Die Novo Holdings managt das Vermögen der Novo-Gruppe, rund 300 Milliarden DKK.
rdf:langString Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation’s assets, which in 2021 was worth almost DKK 700 billion Danish Kroner (approximately US$93.73 billion) and is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings A/S is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore. Eivind Kolding succeeded Henrik Gürtler as CEO on 1 May 2014. Eivind Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO for the organisation. Since 2016 Kasim Kutay has been the CEO of Novo Holdings A/S.
xsd:nonNegativeInteger 26464
<danishKrone> 6.97E11 9.373E10
xsd:gYear 1999

data from the linked data cloud